PL2144929T3 - Poprawa mian polipeptydu czynnika VIII w hodowlach komórkowych - Google Patents

Poprawa mian polipeptydu czynnika VIII w hodowlach komórkowych

Info

Publication number
PL2144929T3
PL2144929T3 PL08749930T PL08749930T PL2144929T3 PL 2144929 T3 PL2144929 T3 PL 2144929T3 PL 08749930 T PL08749930 T PL 08749930T PL 08749930 T PL08749930 T PL 08749930T PL 2144929 T3 PL2144929 T3 PL 2144929T3
Authority
PL
Poland
Prior art keywords
factor viii
viii polypeptide
improvement
cell cultures
titers
Prior art date
Application number
PL08749930T
Other languages
English (en)
Inventor
Laust Bruun Johnsen
Ida Hilden
Gert Bolt
Thomas Dock Steenstrup
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38519867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2144929(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL2144929T3 publication Critical patent/PL2144929T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL08749930T 2007-05-04 2008-04-30 Poprawa mian polipeptydu czynnika VIII w hodowlach komórkowych PL2144929T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07107477A EP1988101A1 (en) 2007-05-04 2007-05-04 Improvement of factor VIII polypeptide titers in cell cultures
EP08749930A EP2144929B1 (en) 2007-05-04 2008-04-30 Improvement of factor viii polypeptide titers in cell cultures
PCT/EP2008/055349 WO2008135501A1 (en) 2007-05-04 2008-04-30 Improvement of factor viii polypeptide titers in cell cultures

Publications (1)

Publication Number Publication Date
PL2144929T3 true PL2144929T3 (pl) 2012-06-29

Family

ID=38519867

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08749930T PL2144929T3 (pl) 2007-05-04 2008-04-30 Poprawa mian polipeptydu czynnika VIII w hodowlach komórkowych

Country Status (14)

Country Link
US (1) US9982033B2 (pl)
EP (2) EP1988101A1 (pl)
JP (1) JP5506664B2 (pl)
KR (1) KR101594805B1 (pl)
CN (1) CN101675073B (pl)
AT (1) ATE540975T1 (pl)
AU (1) AU2008248627B2 (pl)
BR (1) BRPI0811177A2 (pl)
CA (1) CA2684951A1 (pl)
ES (1) ES2379846T3 (pl)
MX (1) MX2009011805A (pl)
PL (1) PL2144929T3 (pl)
RU (1) RU2477318C2 (pl)
WO (1) WO2008135501A1 (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201516149A (zh) 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CA2932207A1 (en) 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
WO2012045769A1 (en) 2010-10-05 2012-04-12 Novo Nordisk Health Care Ag Process for protein production
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN103946235A (zh) * 2011-11-21 2014-07-23 诺沃—诺迪斯克有限公司 用于生产因子viii的方法
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
KR101395736B1 (ko) * 2012-07-10 2014-05-16 아주대학교산학협력단 인간 혈액응고인자 ⅷ 도메인 특이적 항체 및 이의 제조방법
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
NZ724826A (en) * 2014-04-16 2022-07-29 Cmc Biologics As A high cell density fill and draw fermentation process
JP6516829B2 (ja) 2014-08-04 2019-05-22 シーエスエル、リミテッド 第ｖｉｉｉ因子製剤
SG11201706659WA (en) 2015-03-06 2017-09-28 Csl Behring Recombinant Facility Ag Modified von willebrand factor having improved half-life
WO2021001522A1 (en) 2019-07-04 2021-01-07 CSL Behring Lengnau AG A truncated von willebrand factor (vwf) for increasing the in vitro stability of coagulation factor viii
WO2021094344A1 (en) 2019-11-11 2021-05-20 CSL Behring Lengnau AG Polypeptides for inducing tolerance to factor viii
JP2025538565A (ja) 2022-11-23 2025-11-28 エフ． ホフマン－ラ ロシュ アーゲー 組換えタンパク質発現を増加させるための方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US5250421A (en) * 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
ATE87663T1 (de) 1986-01-03 1993-04-15 Genetics Inst Verfahren zur herstellung von faktor-viii:c-typ- proteinen.
DE3769872D1 (de) * 1986-07-11 1991-06-13 Miles Inc Herstellung von rekombinantem protein.
CA1331157C (en) 1987-04-06 1994-08-02 Randal J. Kaufman Method for producing factor viii:c-type proteins
WO1990002175A1 (en) 1988-08-16 1990-03-08 Novo Nordisk A/S A method of producing polypeptides by culturing eukaryotic cells in the presence of protease inhibitors
US5952198A (en) * 1995-05-04 1999-09-14 Bayer Corporation Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition
US5679549A (en) * 1995-05-04 1997-10-21 Bayer Corporation Production of recombinant factor VIII in the presence of liposome-like substances of mixed composition
US5851800A (en) 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein
US6458563B1 (en) * 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6338964B1 (en) 1999-05-07 2002-01-15 Bayer Corporation Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
CA2437015A1 (en) * 2001-02-05 2002-08-15 Novo Nordisk Health Care Ag Combined use of factor vii polypeptides and factor ix polypeptides
US7351688B2 (en) * 2003-02-05 2008-04-01 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein formulations
US20040229793A1 (en) * 2003-02-05 2004-11-18 Balasubramanian Sathyamangalam V. Compositions and methods for less immunogenic protein formulations
EP1707634A1 (en) * 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins

Also Published As

Publication number Publication date
RU2009143635A (ru) 2011-06-10
JP5506664B2 (ja) 2014-05-28
AU2008248627B2 (en) 2013-06-06
US9982033B2 (en) 2018-05-29
KR20100016430A (ko) 2010-02-12
CN101675073A (zh) 2010-03-17
ES2379846T3 (es) 2012-05-04
CA2684951A1 (en) 2008-11-13
JP2010525829A (ja) 2010-07-29
BRPI0811177A2 (pt) 2014-10-29
EP2144929B1 (en) 2012-01-11
MX2009011805A (es) 2009-11-13
EP2144929A1 (en) 2010-01-20
KR101594805B1 (ko) 2016-02-17
CN101675073B (zh) 2013-12-04
US20100120094A1 (en) 2010-05-13
EP1988101A1 (en) 2008-11-05
AU2008248627A1 (en) 2008-11-13
WO2008135501A1 (en) 2008-11-13
RU2477318C2 (ru) 2013-03-10
ATE540975T1 (de) 2012-01-15

Similar Documents

Publication Publication Date Title
MX2009011805A (es) Mejora de las concentraciones de polipeptido del factor viii en cultivos celulares.
IN2012DN05207A (pl)
NZ598677A (en) Production of proteins in glutamine-free cell culture media
EP2438161A4 (en) METHOD FOR THE PRODUCTION OF INDUCED PLURIPOTENTER STEM CELLS AND METHOD FOR THEIR CULTIVATION
EP4148121A3 (en) Cell-controlled perfusion in continuous culture
NZ630551A (en) Methods and means for the production of ig-like molecules
MY181513A (en) Cell culture compositions and methods for polypeptide production
CL2011001926A1 (es) Biorreactor para el cultivo de celulas de mamiferos donde dicho biorreactor posee un volumen de al menos 4000 l y al menos un impulsor superior y al menos un impulsor de fondo, donde el impulsor superior es un impulsor de hidroplano; metodo de cultivo; sistema de bioreactor.
IL210491A0 (en) System and method for controlling a mammalian cell culture process
MY156588A (en) Systems using cell culture for production of isoprene
WO2007098150A3 (en) Photobioreactor and uses therefor
DK2171034T3 (da) Metode til fremstilling af en biopolymer i en kontinuerlig perfusionsgæringsproces
WO2010096588A3 (en) Cell culture media containing combinations of proteins
WO2008154014A3 (en) A method for culturing mammalian cells to improve recombinant protein production
MX351974B (es) Cultivo de celulas de mamifero.
EP2594636A4 (en) CULTURE MEDIUM COMPOSITION FOR CULTURING MESENCHYMAL STEM CELLS FROM AMNIOTIC MEMBRANE, AND METHOD FOR CULTURING THE SAME USING THE SAME
WO2008135498A3 (en) Prevention of protein degradation in mammalian cell cultures
WO2008024769A3 (en) Intensified perfusion production method
EP2582792A4 (en) HEART OF CARDIOMYOCYTES WITH DIALYSATED SERUM
PL1720979T3 (pl) Zastosowanie podłoża pozbawionego surowicy do hodowli komórkowej do wytwarzania IL-18BP w komórkach ssaków
NZ591812A (en) Cell culture method to form aggregates
GB2468624A (en) Cell culture system for pancreatic islands
UA92157C2 (ru) Способ продуцирования гормона роста
GB2450599A (en) Automated culture of stem cells
WO2014049382A3 (en) Ethylenediamine fermentative production by a recombinant microorganism